These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12647982)

  • 1. Advanced NSCLC: from cytotoxic systemic chemotherapy to molecularly targeted therapy.
    Hoang T; Schiller JH
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):393-401. PubMed ID: 12647982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.
    Gridelli C; Massarelli E; Maione P; Rossi A; Herbst RS; Onn A; Ciardiello F
    Cancer; 2004 Oct; 101(8):1733-44. PubMed ID: 15386339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapies for the treatment of non-small cell lung cancer.
    Johnson DH; Schiller JH
    Cancer Chemother Biol Response Modif; 2002; 20():763-86. PubMed ID: 12703233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclooxygenase 2 inhibitors and lung carcinoma].
    Spano JP; Chouahnia K; Morère JF
    Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New targets for the treatment of advanced non-small cell lung cancer.
    Massarelli E; Onn A; Zinner R; Khuri FR; Kim ES; Herbst RS
    Cancer Chemother Biol Response Modif; 2002; 20():717-61. PubMed ID: 12703232
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cyclooxygenase 2 inhibitors and lung carcinoma].
    Spano JP; Chouahnia K; Morère JF
    Bull Cancer; 2004 May; 91 Suppl 2():S109-12. PubMed ID: 15899634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of novel treatment strategies.
    Giaccone G
    Oncogene; 2002 Oct; 21(45):6970-81. PubMed ID: 12362278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase as a target in lung cancer.
    Brown JR; DuBois RN
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
    Liao Z; Milas L; Komaki R; Stevens C; Cox JD
    Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New targets for non-small-cell lung cancer therapy.
    Alvarez M; Roman E; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D; Pyo H; Choy H
    Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel targeted agents in the treatment of lung cancer.
    Saba N; Khuri F
    Expert Opin Investig Drugs; 2004 Jun; 13(6):609-29. PubMed ID: 15174948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology of non-small-cell lung cancer: identifying new targets for rational therapy.
    Rosell R; Felip E; Garcia-Campelo R; Balaña C
    Lung Cancer; 2004 Nov; 46(2):135-48. PubMed ID: 15474661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New biological agents in the treatment of advanced non-small cell lung cancer.
    Morrow PK; Kim ES
    Semin Respir Crit Care Med; 2005 Jun; 26(3):323-32. PubMed ID: 16052434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New chemotherapeutic agents: update of major chemoradiation trials in solid tumors.
    Curran WJ
    Oncology; 2002; 63 Suppl 2():29-38. PubMed ID: 12466642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of targeted therapy in non-small cell lung cancer: hype or hope?
    Langer CJ
    Expert Rev Anticancer Ther; 2003 Aug; 3(4):443-55. PubMed ID: 12934657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel agents in the treatment of non-small cell lung cancer: implications for neoadjuvant chemotherapy?
    Bergqvist M; Henriksson R; Brattström D
    In Vivo; 2005; 19(3):523-33. PubMed ID: 15875771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present trends in the treatment of advanced non small-cell lung cancer.
    Parvez T; Allam AR; Iskandrani A; Khan MA
    J Coll Physicians Surg Pak; 2003 Aug; 13(8):483-90. PubMed ID: 12921691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.